Bull & Bear

Figures converted from KRW at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Watchlist — the order book is real, but the cash conversion, forensic, and customer-concentration questions cannot be resolved at today's price after a +169% twelve-month move. Bull and Bear agree on most underlying facts and disagree on what they mean. The decisive question is whether the FY2025 earnings recovery converts to operating cash flow in H1 FY2026 — both sides anchor their exit/entry triggers to the same disclosure, which makes this a wait-for-the-print situation. The forensic profile (FY2023 restatement, $21.3M PP&E movement, no audit committee, loss-making holding chain) and parabolic tape (RSI 78, 30-day vol 120%) tilt the immediate risk asymmetry against ownership; the real order book and 1.0× P/B floor keep the long thesis alive. The condition that moves this off Watchlist is one printed quarter of positive OCF with revenue ≥$11.9M and YILINING share trending down — until then, paying for the recovery requires faith the cash statement has not yet extended.

Bull Case

Bull commits to $28 per share (market cap ~$124M, ~52% upside from $18.22), set at 12× FY2026E net income of $10–11M and cross-checked against 1.4× P/B on FY2026-end equity of ~$89M. Timeline 12–18 months, anchored on the Q2/Q3 FY2026 quarterly reports and the H2 FY2026 cash conversion turn. Disconfirming signal: YILINING/Yiling Trading revenue dropping below $3.3M in a single quarter without a ≥$6.6M replacement contract surfacing in the single-supply disclosures within 90 days.

Bear Case

Bear commits to $7.92 per share (~$35.4M market cap, −57% from $18.22), set on a blended floor of 0.4× book on $84.6M equity (= $7.23) and 8× a normalized through-cycle EBITDA of ~$3.5M; both methods converge at $7.30–$8.60. Timeline 12–18 months. Primary trigger: a DART disclosure that YILINING's order share is dropping — through pause, BIS sweep, or Korean alignment with US back-end controls. Cover signal: two consecutive quarters of positive OCF with YILINING below 30% of revenue and no new equity or CB filing in the same window.

The Real Debate

Verdict

Watchlist. The Bear carries slightly more weight today, not on the durable thesis but on timing: the forensic profile and parabolic tape (RSI 78, 30-day vol 120%, +110% above the 200-day SMA after +169% twelve-month gains) raise the standard of proof above what the FY2025 financials currently meet. The most important tension is cash conversion — timing or structural? — both sides have anchored their exit/entry signals to the same future disclosure (H1 FY2026 OCF), and it has not yet arrived. The Bull could still be right: the order book is real, contracts are signed and dated in DART, the geopolitical wedge favours Mirae, and 1.0× P/B is a genuine floor on a recapitalised balance sheet. The condition that would move this from Watchlist to Lean Long is one quarterly report showing OCF turning positive while revenue holds ≥$11.9M, with no new equity issuance or convertible filing in the same window. The marker that would tip the other way is any YILINING share decline in the next quarterly customer disclosure without a ≥$6.6M replacement contract surfacing within 90 days; if that prints, Bear's downside target becomes the operative anchor.